TrialJAMA
Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial.
Mark S Sulkowski et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
136 papers cite itlatest 60 shown
pooled ittrialcites it